Information Provided By:
Fly News Breaks for August 10, 2015
ESPR
Aug 10, 2015 | 07:31 EDT
Needham upgraded Esperion to Strong Buy with a $130 price target following the recent pullback on regulatory concerns. The firm is confident the FDA will agree to a development plan for ETC-1002 targeting a broad based label for LDL reduction.
News For ESPR From the Last 2 Days
There are no results for your query ESPR